Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
Section of Gastroenterology and Hepatology, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
Am J Gastroenterol. 2017 Aug;112(8):1287-1297. doi: 10.1038/ajg.2017.175. Epub 2017 Jun 13.
Recent data suggest decreasing in-patient mortality in patients hospitalized with cirrhosis. We sought to determine if improvements in short-term outcomes for patients with cirrhosis are associated with changes in longer-term outcomes.
We examined temporal trends in 30 days and 1-year postdischarge mortality among patients hospitalized with cirrhosis at any of the 126 Veterans Administration hospitals from 2004 and 2013. We adjusted for a range of demographic, liver disease severity, and comorbidity-related factors to account for differences in patient cohorts over time.
We identified 109,358 unique patients who were hospitalized with cirrhosis between 2004 and 2013. In-hospital mortality decreased from 11.4 to 7.6%, whereas 1-year mortality decreased from 34.5 to 33.2%. Over a third of out-of-hospital deaths occurred within the first 30 days after discharge; 30-day mortality increased from 9.3 to 10.1%. After adjusting for patient factors, the odds of in-hospital mortality in 2013 were 30% lower (adjusted odds ratio (OR)=0.70, 95% confidence interval (CI), 0.64-0.78), 1-year mortality were 13% lower (adjusted OR=0.87, 95% CI=0.82-0.93), whereas the 30-day mortality were 10% higher than 2004 (adjusted OR=1.10, 95% CI=0.99-1.21), although the latter did not reach statistical significance.
In patients admitted with cirrhosis, reduction in in-hospital mortality was associated with less marked reduction in 1-year mortality, and an unchanged, if not higher, 30-day mortality following discharge. Our data suggest that some of the burden of mortality in cirrhosis has shifted from in-hospital to the immediate postdischarge period.
最近的数据表明,肝硬化住院患者的住院病死率有所下降。我们试图确定肝硬化患者短期预后的改善是否与长期预后的变化相关。
我们分析了 2004 年至 2013 年期间在退伍军人事务部 126 家医院中因肝硬化住院的患者在 30 天和 1 年出院后死亡率的时间趋势。我们调整了一系列与人口统计学、肝病严重程度和合并症相关的因素,以说明随时间推移患者队列的差异。
我们确定了 2004 年至 2013 年间 109358 例因肝硬化住院的患者。院内死亡率从 11.4%降至 7.6%,1 年死亡率从 34.5%降至 33.2%。出院后 30 天内发生的院外死亡超过三分之一;30 天死亡率从 9.3%升至 10.1%。在调整患者因素后,2013 年的院内死亡率降低了 30%(调整后的优势比(OR)=0.70,95%置信区间(CI),0.64-0.78),1 年死亡率降低了 13%(调整后的 OR=0.87,95% CI=0.82-0.93),而 30 天死亡率则比 2004 年高出 10%(调整后的 OR=1.10,95% CI=0.99-1.21),尽管后者没有达到统计学意义。
在因肝硬化住院的患者中,院内死亡率的降低与 1 年死亡率的显著降低相关,而出院后 30 天的死亡率不变,如果不是更高的话,则不变。我们的数据表明,肝硬化患者的部分死亡负担已经从院内转移到了出院后的立即阶段。